16
N-Glycan Analysis: Better Together Agilent and ProZyme sample preparation workflow

N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

N-Glycan Analysis: Better TogetherAgilent and ProZyme sample preparation workflow

Page 2: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

2

The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics, and pharmacodynamics of therapeutic proteins such as monoclonal antibodies (mAbs) and Fc fusion proteins. That’s why N-glycan characterization is essential to the biotherapeutic development process.1,2

A common N-glycan characterization method involves labeling enzymatically released glycans to enable fluorescence detection (FLD) and to enhance ionization for mass spectrometry (MS). These labeled glycans are separated by liquid chromatography (LC) or capillary electrophoresis (CE), with relative quantitation enabled by FLD and mass confirmation by MS detection. Hydrophilic interaction liquid chromatography (HILIC) is the most popular separation technique for labeled N-glycans.

Push Your Glycoprotein Analysis to New Levels of Performance

Page 3: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

3

End-to-end workflows for N-glycan sample preparation and analysis With our integration of ProZyme glycoanalysis products, Agilent now offers several sample preparation options for N-glycans to support your LC/FLD/MS and CE workflows (Figure 1):

– Gly-X, our newest product. Shortening sample preparation time to one hour, it uses a five-minute PNGase F digestion and InstantPC—a glycosylamine labeling dye with high FLD and MS signal. Labeling with 2-AB and APTS is also available with a workflow time of about two hours.

– GlykoPrep, an earlier generation spin-based kit. It is based on AssayMAP cartridges introduced in 2012 with a workflow time of three to five hours.

– Tools to support more traditional methods.

These modular workflows are available with several different glycan labels, and are supported by a wide portfolio of labeled and unlabeled glycan standards and libraries.

Together with AdvanceBio Glycan Mapping HILIC columns and instrumentation for LC and MS, Agilent now supports your entire released glycan workflow.

!"#!$#!$! %&'()*+*,'-.(/+*(01234(5&6(7&'(8+*(91(:9,;1&+69-(<'&-*:8'*+4

IPC

Automation Sample Prep Separation Detection Data Processing and Report

AssayMAP Bravo Liquid Handler

GlykoPrep InstantPC, InstantAB, 2-AB, APTS

Glycan analysis reagents

Gly-X InstantPC

Gly-X 2-AB Express EnzymesStandards

1260 Infinity II Bio-Inert

1290 Infinity II LC

AdvanceBio Glycan Mapping columns (HILIC)

6545XT AdvanceBio LC/Q-TOF

MassHunter BioConfirm B.10.00 software

Tagged library

Dedicated released glycan InstantPC workflow

Figure 1. The evolution of N-glycan sample preparation (times are shown on the right).

1–2 daysFirst generation

Figure 2. Agilent released N-glycan workflow elements.

3–4 hours

4–5 hours

GlykoPrep with InstantDyes

GlykoPrep with traditional reductive amination dyes

Second generation

Third generation

2 hours

Gly-X with InstantDyes

Gly-X with 2-AB or APTS (Express)

1 hour

Traditional deglycosylation with traditional reductive amination dyes

Page 4: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

4

Gly-X is a next-generation N-glycan preparation platform that provides a rapid, simplified, in-solution workflow. It uses a five-minute PNGase F digestion—combined with InstantPC dye and an efficient vacuum plate cleanup step—to remove excess label and denaturant. That means your samples can be ready for UHPLC with high-signal FLD and/or MS detection in 60 minutes or less (Figure 3).

Do you want to continue using the 2-aminobenzamide (2-AB) label to compare with historical data? The Gly-X platform supports 2-AB labeling with 2-AB Express, where glycans are immobilized on the cleanup matrix before labeling, which eliminates the need for dry down.

CE separations of N-glycans are also supported by the APTS (8-Aminopyrene-1,3,6-trisulfonic acid) Express kit. 2-AB Express and APTS Express workflows take about two hours, due to the additional hour required for labeling via heated reductive amination reaction.

Gly-X N-Glycan Sample Preparation

Figure 3. Gly-X N-glycan sample preparation workflow. The recommended starting sample amount is 1 to 40 µg, which is a higher maximum sample amount than similar workflows. You may also be able to use more protein, depending on the molecule. For further sample considerations, please see the individual Gly-X product manuals.

Dye

Gly-X N-glycan sample preparation workflow

Denature 3 min at 90 °C

DeglycosylatePNGase F, 5 min at 50 °C

LabelInstantDye, 1 min 5 min at 50 °C InstantPC Reductive amination dye, 60 min (no dry down) 2-AB, APTS

Labeled N-glycansLC-FLR, LC-MS, CE

Clean up15-20 min at RT

Page 5: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

5

Gly-X sample preparation is robust and reproducibleAll reagents—including N-glycanase (PNGase F) enzyme—are supplied, except for common reagents such as acetonitrile, formic acid, and water. Using a 96-well format for the vacuum-driven cleanup plate, anywhere from 1 to 96 samples may be processed per run. The used wells of the cleanup plate are sealed before storage at room temperature. Partially used reagents may be returned to the appropriate storage conditions for re-use (see instruction manuals for details). Separation of InstantPC labeled N-glycans from rituximab is shown in Figure 4, along with relative percent area data.

Figure 4. HILIC-UHPLC fluorescence profile of Rituxan N-glycans prepared with Gly-X InstantPC. N-Glycan relative percent areas are shown in the table. Data from application note 5994-1348EN.

Rituximab N-glycans, Gly-X InstantPC

×101

00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0

Acquisition time (minutes)5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

G2FS2G2FS1[6]G2F

G1F[3]

G1F[6]

G1[6]Man5

G0F

G0G0F-N

×101

00.10.20.30.40.50.60.70.80.91.01.11.21.31.41.51.61.7

G2FS2

G2S2

G2FS1[3]

G2F

S1[6

]

G2S

1[6]

G2S1[3]

G1F

S1

G2F

G2G1F[3]

G1F[6]

G1[6]

Man5

G0F

G0G0F-N

Acquisition time (minutes)5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

BEnbrel, InstantPC

Resp

onse

uni

tsRe

spon

se u

nits

(%)

Publication Document Title

5994-1348EN Application note Streamlined Workflows for N-Glycan Analysis of Biotherapeutics Using Agilent AdvanceBio Gly-X InstantPC and 2-AB Express Sample Preparation with LC/FLD/MS

5994-0682EN Application note Preparation of Released N-Glycan Samples from Monoclonal Antibodies Using Agilent AdvanceBio Gly-X 2-AB Express for LC-Fluorescence Analysis

5994-0944EN Application note Development of a Rapid APTS Sample Preparation Workflow for N-Glycan Release and Labeling

5994-1231EN User manual Agilent AdvanceBio Gly-X N-Glycan Prep with InstantPC Kit (p/n GX24-IPC and GX96-IPC)

5994-1228EN User manual Agilent AdvanceBio Gly-X N-Glycan Prep with 2-AB Express Kit (p/n GX24-2AB and GX96-2AB)

5994-1229EN User manual Agilent Gly-X N-Glycan Rapid Release and Labeling with APTS Express Kit (p/n GX96-APTS)

To learn more about Gly-X, consult these resources or visit our Gly-X webpage.

Average Rel% Area

Standard Deviation %CV

G0F-N 0.75 0.01 1.55

G0 1.47 0.02 1.18

G0F 46.82 0.07 0.15

Man5 1.21 0.01 0.83

G1[6] 0.75 0.02 2.67

G1F[6] 31.21 0.11 0.35

G1F[3] 9.27 0.05 0.54

G2F 7.04 0.04 0.51

G2FS1[6] 0.67 0.02 2.29

G2FS1[3] 0.37 0.06 15.98

G2FS2 0.45 0.03 6.67

Relative % area, SD, and %CV values for Rituxan N-glycans labeled with InstantPC, n = 4.

Page 6: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

6

GlykoPrep N-Glycan Sample Preparation

Released in 2012, ProZyme GlykoPrep solid phase cartridges were the first platform to use “instant” glycan labeling (Figure 5). The cartridges streamlined and standardized N-glycan sample preparation in both spin and automation (AssayMAP Bravo) formats. Reproducibility was demonstrated in two interlaboratory studies using LC3 and CE4. Although GlykoPrep has been superseded by Gly-X, we continue to support existing GlykoPrep customers.

Figure 5. GlykoPrep N-glycan sample preparation workflow. Many labeling options are available, including InstantPC, 2-AB, and InstantAB, APTS.

Purify antibody (30–60 minutes)

Denature and immobilize (30–60 minutes)

Digest with N-glycanase (15–60 minutes)

Fluorescent labeling (0–1 hour)

Clean up and elute (15–30 minutes)

GlykoPrep N-glycan sample preparation workflow

Publication Document Title

5994-0942EN Application note Comparison of Common Fluorescent Labels for LC/MS Analysis of Released N-Linked Glycans

5991-8550EN Application note A Comprehensive Approach for Monoclonal Antibody N-linked Glycan Analysis from Sample Preparation to Data Analysis

5991-6958EN Application note Comparison of Relative Quantification of Monoclonal Antibody N-Glycans Using Fluorescence and MS Detection

5991-0871EN Application note Analysis of Monoclonal Antibody N-Glycans by Fluorescence Detection and Robust Mass Selective Detection Using the Agilent LC/MSD XT

To learn more about GlykoPrep, consult these resources or visit our GlykoPrep webpage.

Page 7: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

7

Older N-glycan sample preparation workflows include native or denaturant-driven digestion with PNGase F, purification of released glycans, labeling with a fluorophore, and purification of labeled glycans. These workflows take 1 to 2 days, and are not suitable for high-throughput applications or automation.

With the introduction of Gly-X, we can help you transition from a 2-AB workflow to faster sample preparation techniques with higher throughput. However, we will continue to support traditional workflows with a range of glycan labeling and cleanup tools.

Publication Document Title

5994-1056EN Data sheet AdvanceBio N-Glycanase (PNGase F) ≥2.5 U/mL (p/n GKE-5006)

GKK-804 User guide 2-AB-plus Labeling Kit (p/n GKK-804)

GKI-4756 User guide GlycoClean R Cartridges (p/n GKI-4756)

GKI-4025 User guide GlycoClean H Cartridges (p/n GKI-4025)

GKI-4726 User guide GlycoClean S Cartridges (p/n GKI-4726)

5991-9561 User guide AdvanceBio N-Glycan Sample Preparation Kit (p/n 5190-8005)

To learn more about our products for traditional glycan preparation, consult these resources or visit our traditional glycan preparation webpage.

Traditional Methods for N-Glycan Sample Preparation

Page 8: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

8

Glycan labelsYou can label N-glycans with InstantDyes such as InstantPC, or traditional dyes such as 2-AB for HILIC, or APTS for CE, summarized in Figure 6. Keep in mind that reductive amination requires a heated labeling reaction of an hour or more, so sample preparation will take longer. Glycan labeling dyes have differences in UHPLC-HILIC retention time and selectivity, although retention order remains relatively consistent.5

– InstantDye for LC/FLD/MS – Strong FLD and MS signal

– 1st generation InstantDye for LC/FLD – Lower MS signal – Different structure from 2-AB

– Label makes N-glycan less polar – Improves HILIC separation for UHPLC – Well-established glycan label

– Label makes N-glycan more polar – Introduces negative charge for CE

Figure 6. Glycan labeling options.

In addition to high FLD signal in LC, InstantPC contains a tertiary amine that generates high MS signal in positive mode. Unlabeled glycans, as well as traditional labels for glycan analysis such as 2-AB and 2-AA, ionize poorly in MS.

InstantPC had the highest FLD signal of the glycan labels, shown in Figure 7. The second-best label for fluorescence was procainamide, which is added to glycans by reductive amination—a more time-intensive workflow.

Insta

ntPC

RapiFl

uor-M

S

Proca

inam

ide

2-AB

3.0E+5

2.5E+5

2.0E+5

1.5E+5

1.0E+5

5.0E+4

0

FLD

peak

are

a of

G0F

Insta

ntPC

RapiFl

uor-M

S

Proca

inam

ide

2-AB

3.0E+5

2.5E+5

2.0E+5

1.5E+5

1.0E+5

5.0E+4

0

Extra

cted

MS

peak

are

a of

G0F

Fluorescence MS

A B

Figure 7. Comparison of FLD (A) and MS (B) response of glycan labels. Glycans from equal amounts of glycoprotein samples were labeled with InstantPC, RapiFluor-MS, procainamide, and 2-AB according to manufacturer instructions, and measured by UHPLC. Bars represent the peak area of G0F N-glycan species.

HN

OHO

OH

Glycan

NHAc

OH

CH2O(R)

2-AA

APTS

2-AB

H2O N 2H

InstantPCNH

OO

O

N

InstantAB

NH

O

O

NH2

Glycoprotein

GlycoproteinN-glycanase

N-glycanase

InstantDyes

Reductive Amination

A B

Page 9: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

9

N-Glycan StandardsWe offer purified glycan standards in both labeled and unlabeled forms. Supported labels include InstantPC, 2-AB, 2-AA, and APTS. All can be used as qualitative standards for procedures such as LC/FLD, LC/MS, CE/LIF, and CE/MS.

Many common glycan types seen in biotherapeutics are covered, including complex biantennary neutral and sialylated, high mannose, and alpha gal. You can also choose from several glycan libraries for glycoproteins such as:

– Human IgG

– Bovine RNase B

– Bovine fetuin

– Human α1-acid glycoprotein (AGP)

– Recombinant monoclonal IgG (mAb) made in Chinese hamster ovary (CHO) cells

– Triantennary and tetraantennary sialylated N-glycan libraries

In addition, we offer both α(2,3) and (α2,6) sialylation within these standards.

– The α(2,3) sialic acid linkage is found on glycoproteins produced in CHO cells.6 Glycans with α(2,3) sialylation have shorter HILIC retention times than isomeric N-glycans with α(2,6) sialic acid linkages.7

– The α(2,6) sialic acid linkage is found on glycoproteins such as human intravenous immunoglobulin (IVIG).8

For a list of individual N-glycan standards, libraries, and glucose unit (GU) ladders, along with structures and alternative nomenclatures, see publication 5994-0999EN.

To explore our full range of N-glycan standards, visit the Agilent website.

Page 10: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

10

Agilent now offers a variety of glycoenzymes to support your released glycan and other analytical workflows. A selection of our enzymes is shown in Figure 8. Please visit the Agilent website for our full range.

– Endoglycosidases cleave within a glycan structure. N-glycanase (PNGase F, technically an asparagine amidase) is widely used to study released glycans and to generate de-N-glycosylated protein, because it releases most intact N-glycans.

– Exoglycosidases cleave exposed or “terminal” monosaccharide residue from glycans. Commonly used exoglycosidases include galactosidase for degalactosylation and sialidase (neuraminidase) for desialylation of released glycans, glycoproteins, or cells.

– Glycosyltransferases catalyze the addition of a specific monosaccharide to an existing glycan structure, either free or while attached to a protein, sugar, or lipid. Each enzyme type adds a specific monosaccharide. Applications include modifying glycans to a glycoprotein protein in vitro in order to “glycoengineer” a desired glycan profile. Our sialyltransferases and galactosyltransferases also include the appropriate sialic acid or galactose donor substrates.

Glycoenzymes

Page 11: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

11

Sialidase A (p/n GK80040)

Sialidase S (p/n GK80021)

α(2,6)

α(2,3)

β-Galactosidase (p/n GKX-5012, -5013, -5014)

β-Hexosaminidase (p/n GKX-5023, -5003)

α-Fucosidase (p/n GKX-5006)

α-Galactosidase (p/n GKX-5007)

Ser/Thr

O-Glycanase (p/n GK80090)

α-Mannosidase(p/n GKX-5009)

α-Mannosidase(p/n GKX-5010)

Gal GalNAc

A. Endoglycosidases

B. Exoglycosidases

Asn

Endo H (p/n GKE -5002)

N-Glycanase (PNGase F) (p/n GKE-5006, -5016, -5010, -5020)

Endo F2 (p/n GKE -5008)

Asn

PNGase F NeuAc

Gal

GlcNAc

Man

Fuc

C. Glycosyltransferases

β(1,4)-Galactosyltransferase (p/n GKT-GA14)

α(2,3)-Sialyltransferase (p/n GKT-S23)

α(2,6)-Sialyltransferase (p/n GKT-S26)

α(2,3)

α(2,6) ++

+

Neu5Ac Man Fuc

Gal

α(2,6)

GlcNAcα(2,3)

Specificities for selected endoglycosidases (A), exoglycosidases (B), and glycosyltransferases (C)

Glycan cartoons follow the recommendations of the Consortium for Functional Glycomics9 (CFG) and were drawn using GlycoWorkbench 2.14.10

Neu5Ac = N-acetylneuraminic acid Gal = galactose Man = mannose GlcNAc = N-acetylglucosamine Fuc = fucose

Publication Document Title

5994-1225EN Data sheet Sialidase A (p/n GK80040)

GKT-S23 Data sheet α(2,3)-Sialyltransferase (p/n GKT-S23)

GKT-S26 Data sheet α(2,6)-Sialyltransferase (p/n GKT-S26)

GKT-GA14 Data sheet β(1,4)-Galactosyltransferase (p/n GKT-GA14)

GalNAc = N-acetylgalactosamine Asn = asparagine Ser = serine Thr = threonine

To learn more about glycoenzymes, consult these resources or visit our glycobiology enzymes webpage.

Sialidase A (p/n GK80040)

Sialidase S (p/n GK80021)

α(2,6)

α(2,3)

β-Galactosidase (p/n GKX-5012, -5013, -5014)

β-Hexosaminidase (p/n GKX-5023, -5003)

α-Fucosidase (p/n GKX-5006)

α-Galactosidase (p/n GKX-5007)

Ser/Thr

O-Glycanase (p/n GK80090)

α-Mannosidase(p/n GKX-5009)

α-Mannosidase(p/n GKX-5010)

Gal GalNAc

A. Endoglycosidases

B. Exoglycosidases

Asn

Endo H (p/n GKE -5002)

N-Glycanase (PNGase F) (p/n GKE-5006, -5016, -5010, -5020)

Endo F2 (p/n GKE -5008)

Asn

PNGase F NeuAc

Gal

GlcNAc

Man

Fuc

C. Glycosyltransferases

β(1,4)-Galactosyltransferase (p/n GKT-GA14)

α(2,3)-Sialyltransferase (p/n GKT-S23)

α(2,6)-Sialyltransferase (p/n GKT-S26)

α(2,3)

α(2,6) ++

+

Neu5Ac Man Fuc

Gal

α(2,6)

GlcNAcα(2,3)

Glycan structure key

Figure 8. Specificities for selected A) endoglycosidases; B) exoglycosidases; and C) glycosyltransferases.

Page 12: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

FPO

12

In the race to discover and develop the next promising biotherapeutic, or develop a comparable biosimilar, you cannot compromise on analytical accuracy and efficiency. Reducing process development time, making procedural changes, and controlling costs are just a few of the challenges you face every day.

Once you have generated your labeled N-glycan samples using Gly-X sample prep, use Agilent AdvanceBio Glycan Mapping columns for HILIC separation of labeled N-glycans. These amide-based columns have a unique hydrophilic bonding and are available in two configurations:

– 1.8 µm fully porous for speed and performance (1200 bar)

– 2.7 µm superficially porous for resolution at lower pressures (600 bar)

HILIC methods for N-glycan separation using the AdvanceBio Glycan Mapping columns are within the literature in Tables 1 and 2, and separation of InstantPC labeled N-glycans from Enbrel on a 2.1 × 150 mm, 1.8 μm column (p/n 859700-913) using a 60-minute method is shown in Figure 9.

AdvanceBio Glycan Mapping Columns Deliver High Speed and Resolution

AdvanceBio Glycan Mapping columns deliver consistent, exceptional performance for separating and characterizing peptides, proteins, antibodies, conjugates, new biological entities, and biopharmaceuticals. Many column lengths are available.

Page 13: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

13

AdvanceBio Gycan Mapping HILIC columns help you overcome difficult glycan analysis challenges

Publication Document Title

5994-1469EN Application note Separation of a Critical Pair of N-Glycans Using a Quality by Design (QbD) Approach

5994-0372EN Application note Glycopeptide Characterization for Various Monoclonal Antibodies Using the Agilent 6545XT AdvanceBio LC/Q-TOF

5994-8796EN Application note Profiling Glycosylation of Monoclonal Antibodies at Three Levels Using the Agilent 6545XT AdvanceBio LC/Q-TOF

5994-8550EN Application note A Comprehensive Approach for Monoclonal Antibody N-linked Glycan Analysis from Sample Preparation to Data Analysis

Figure 9. Separation of InstantPC N-glycans from Enbrel (etanercept) on a 2.1 × 150 mm, 1.8 μm column (p/n 859700-913) using a 60-minute method. A) Fluorescence detection, B) MS detection.

x101

00.10.20.30.40.50.60.70.80.91.01.11.21.31.41.51.61.7

Resp

onse

uni

ts

5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31Acquisition time (minutes)

x108

0.30.40.50.60.70.80.91.01.11.21.31.41.51.61.71.81.92.02.1

5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31Acquisition time (minutes)

G0F

G0F

G1F[3]

G1F[6]

G2F

G2FS1[3]

G2FS2

G2S1[3]

Man5

Resp

onse

uni

ts

G1F[3]

G1F[6]

G2F

G2FS1[3]

G2FS2

G2S1[3]

Man5

Enbrel, InstantPC FLD

Enbrel, InstantPC TIC

A

B

To learn more about AdvanceBio Glycan Mapping columns, consult these resources or visit our Glycan Mapping column webpage.

Page 14: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

14

Insights from the experts can help ensure the success of your drug development program. Agilent offers services for released glycan analysis with reporting options including:

– LC/FLD for relative percent area

– LC/MS for glycan peak ID

– Using standards and exoglycosidases to confirm glycan peak assignment

– Generating glycovariants using exoglycosidases and glycosyltransferases to suit the needs of your study

If you have limited instrumentation or personnel, or are under tight time constraints, no problem. We can partner with you to develop and implement a glycan analysis method with a quick data turnaround time. What’s more, we perform many of our analytical services with off-the-shelf products, allowing for easier method transfer when you choose to bring the analysis into your lab.

To discuss your individual project needs, contact us at [email protected].

Analytical Services to Support Your N-Glycan Analysis

Page 15: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

15

References

1. Jones, A. N-Glycan Analysis of Biotherapeutic Proteins. BioPharm International. 2017, 30(6), 20–25.

2. Planinc, A. et al. Glycan characterization of biopharmaceuticals: Updates and perspectives. Anal Chim Acta. 2016, 921, 13–27.

3. Szekrényes, Á. et al. Multi-site N-Glycan Mapping study 2: UHPLC. Electrophoresis. 2018, 39(7), 998–1005.

4. Szekrényes, Á. et al. Multi-site N-Glycan Mapping study 1: Capillary electrophoresis - laser induced fluorescence. MAbs. 2016, 8(1), 56–64.

5. Yan, J. et al. Comparison of Common Fluorescent Labels for LC/MS Analysis of Released N-Linked Glycans. Agilent Technologies application note, publication number 5994-0942EN, 2019.

6. Lee, E.U. et al. Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of beta-galactoside alpha 2,6-sialyltransferase. J Biol Chem. 1989, 264(23), 13848–55.

7. Anthony, R.M. et al. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science. 2008, 320(5874), 373–6.

8. Raymond C. et al. Production of α2,6-sialylated IgG1 in CHO cells. MAbs. 2015, 7(3), 571–83.

9. Varki, A. et al. Symbol Nomenclature for Graphical Representations of Glycans. Glycobiology. 2015, 25(12), 1323–4.

10. Ceroni, A. et al. GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. J Proteome Res. 2008, 7(4), 1650–9.

Page 16: N-Glycan Analysis: Better Together · Better Together. Agilent and ProZyme sample preparation workflow. 2 The structure of N-linked glycans can affect the immunogenicity, pharmacokinetics,

Agilent CrossLab servicesCrossLab is an Agilent capability that integrates services and consumables to support workflow success and important outcomes like improved productivity and operational efficiency. Through CrossLab, Agilent strives to provide insight in every interaction to help you achieve your goals. CrossLab offers method optimization, flexible service plans, and training for all skill levels. We have many other products and services to help you manage your instruments and your lab for best performance.

Learn more about Agilent CrossLab, and see examples of insight that leads to great outcomes, at www.agilent.com/crosslab

Learn more: www.agilent.com/chem/glycananalysis

Buy online: www.agilent.com/chem/store

Find a local Agilent customer center in your country: www.agilent.com/chem/contactus

U.S. and Canada 1-800-227-9770 [email protected]

Europe [email protected]

Asia Pacific [email protected]

For Research Use Only. Not for use in diagnostic procedures.DE.9254398148

This information is subject to change without notice.

© Agilent Technologies, Inc. 2020 Published in the USA, May 21, 2020 5994-1647EN